AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 520

The date is set - new trademark law will be in force June 2019

Smart & Biggar/Fetherstonhaugh
Canada
December 3 2018

After years of uncertainty, a date has been set for the implementation of Canada's new Trademark Law, which will come into force on 17 June 2019. The

Canada’s new Patent Rules: twelve notable changes and tips

Smart & Biggar/Fetherstonhaugh
Canada
December 3 2018

On December 1, 2018, the Canadian government released its proposed new Patent Rules in the Canada Gazette, Part I. This is one of the last steps

Anti-dilution remedy not limited to registered trademarks

Smart & Biggar/Fetherstonhaugh
Canada
December 3 2018

Section 22 of the Trademarks Act, depreciation of a registered trademark's goodwill, is a potentially powerful yet generally underused weapon for

Supreme Court of Canada Leave Applications

Smart & Biggar/Fetherstonhaugh
Canada
November 30 2018

Supreme Court of Canada denies Eli Lilly leave to appeal in olanzapine section 8 damages action. On November 8, 2018, Eli Lilly was denied

PMPRB amendments will likely not be implemented by January 2019

Smart & Biggar/Fetherstonhaugh
Canada
November 30 2018

We previously reported on proposed amendments to the Patented Medicines Regulationsreleased on December 2, 2017. The originally proposed coming

Common invalidity issues in FAMPYRA PMNOC actions against Taro and Apotex to be heard concurrently

Smart & Biggar/Fetherstonhaugh
Canada
November 30 2018

On October 16, 2018, Prothonotary Tabib ordered that common validity issues in actions relating to Biogen's fampridine (FAMPYRA) against Taro

Ontario Court of Appeal allows Sanofi and Schering to plead that Federal Court ramipril patent invalidity decision was flawed due to “promise doctrine”

Smart & Biggar/Fetherstonhaugh
Canada
November 29 2018

In an action by Apotex for compensation from Sanofi and Schering under the Ontario Statute of Monopolies, U.K. Statute of Monopolies and the

Divided success in Sandoz’s motion to strike monetary remedies and other novel claims in rituximab PMNOC actions

Smart & Biggar/Fetherstonhaugh
Canada
November 29 2018

A Federal Court Order has issued on a motion to strike brought by Sandoz in four actions relating to infringement of rituximab patents. The Court’s

CADTH releases Environmental Scan on International Policies on Use of Biosimilars

Smart & Biggar/Fetherstonhaugh
Canada
November 29 2018

In October 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) issued an interesting Environmental Scan on International Policies

Apotex not permitted to plead promise-based invalidity grounds in Section 8 lansoprazole action

Smart & Biggar/Fetherstonhaugh
Canada
November 19 2018

The Ontario Superior Court of Justice recently dismissed Apotex's motion to plead promise-based invalidity grounds in a Section 8 lansoprazole action

Search techniques

Current Search

Refine

Content type

Tags